language_icon
EN
HI

Medplus Health Services Share price

MEDPLUS

869.8

8.00 (-0.91%)
NSE
BSE
Last updated on 20 Apr, 2026 | 15:54 IST
Today's High

885.80

Today's Low

862.70

52 Week Low

732.00

52 Week High

1045.30

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Medplus Health Services Chart

Medplus Health Services Share Key Metrics

Volume
45129.00
Market Cap
10442.35 CR
LTQ@LTP
1@869.80
ATP
876.53
Var Margin
14.99 %
Circuit Range
702.25-1053.35
Delivery %
70.79 %
Value
3.96 CR
ASM/GSM
No
Market Lot
1

Summary

Medplus Health Services share price stands at ₹869.8 at 20 Apr, 2026 | 15:54. The stock Medplus Health Services intraday movement has stayed between ₹862.70 and ₹885.80, while on a 52-week basis it has fluctuated from ₹732.00 to ₹1045.30.
In terms of trading activity, Medplus Health Services has recorded a volume of 45129 shares. The Medplus Health Services has a market cap of ₹120054642. The stock’s Average Traded Price (ATP) stands at ₹87653, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 86980.
The Medplus Health Services operates within a circuit range of ₹702.25-1053.35 – ₹702.25-1053.35, with a Value of ₹3.96 CR. The Delivery Percentage for the day is 70.79%. Additionally, Medplus Health Services currently falls under the No framework, and trades with a market lot size of 1.

Medplus Health Services Fundamentals

View More
P/E Ratio

50.89

P/B Ratio

5.54

Div. Yield

0

Sector P/E

70.17

Sector P/B

3.8

Sec. Div. Yield

0.19

Medplus Health Services Resistance and Support

Pivot 875.58

Resistance

First Resistance

888.56

Second Resistance

899.33

Third Resistance

912.31

Support

First Support

864.81

Second Support

851.83

Third Support

841.06

Medplus Health Services Shareholding Pattern

View More
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

40.22%

Mutual Fund

22.6%

Insurance

2.37%

Foreign Institutional Investors

15.53%

Domestic Institutional Investors

2.85%

Retail

16.44%

Others

-0.01%

Total Promoters
MAR '26
40.22%

Medplus Health Services Corporate Actions

DateAgenda
2026-05-29Audited Results
2026-01-30Quarterly Results
2025-10-31Quarterly Results
2025-08-02Quarterly Results
2025-05-27Audited Results
2025-01-31Quarterly Results

Medplus Health Services News

Medplus Health Services Limited

MedPlus subsidiary Optival Health Solutions received two drug license suspension orders in Karnataka. The suspensions, for 4 and 5 days, could lead to a total revenue loss of ₹4.98 lakhs.
Apr 17 2026 17:04:00

Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

MedPlus Health's subsidiary Optival Health Solutions received two drug license suspension orders, leading to a potential revenue loss of ₹6.81 lacs. The orders were issued by drug control authorities in Andhra Pradesh and Odisha for rule violations.
Apr 15 2026 17:04:00

Medplus Health Services Limited

MedPlus Health Services' subsidiary, Optival Health Solutions, received two drug license suspension orders for its stores in Eluru and Bhubaneswar. These orders could result in a total potential revenue loss of ₹6.81 lakhs due to violations of the Drugs and Cosmetics Act.
Apr 15 2026 17:04:00

Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Optival Health Solutions Private Limited, a subsidiary of MedPlus, received a five-day drug license suspension for a store in Odisha. This regulatory action, which was received on April 10, 2026, carries a potential revenue loss of ₹3.80 lakhs.
Apr 11 2026 12:04:00

Medplus Health Services Limited

MedPlus Health Services' subsidiary, Optival Health Solutions, received a 5-day drug license suspension for a drug license in Odisha. This action by the Dy. Drugs Controller is expected to result in a potential revenue loss of ₹3.80 lakhs for the company.
Apr 11 2026 12:04:00

Medplus Health Services Limited

MedPlus subsidiary Optival Health Solutions' drug license was suspended for two days for a store in Jadcherla, Telangana, on April 08, 2026. This regulatory action carries a minimal potential revenue loss of ₹0.28 lacs.
Apr 09 2026 18:04:00

Medplus Health Services Limited

MedPlus subsidiary Optival Health Solutions faced a 2-day drug license suspension for a store in Telangana. The incident could result in a potential revenue loss of ₹0.16 lakhs and was issued by the Assistant Director, Drugs Control Administration.
Apr 03 2026 16:04:00

Medplus Health Services Limited

MedPlus's subsidiary, Optival Health Solutions, received a three-day drug license suspension for one of its stores in Warangal, Telangana. This regulatory action carries a potential revenue loss of ₹0.60 lakhs.
Mar 29 2026 17:03:00

Medplus Health Services Limited

Medplus Health Services board will convene on May 29, 2026, to approve the standalone and cons. financial results for the full fiscal year 2026. This meeting is crucial for reviewing the company's annual performance.
Mar 28 2026 17:03:00

Medplus Health Services Ltd - 543427 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("SEBI LODR ")

MedPlus Health Services Board to meet on May 29, 2026, to approve the audited standalone and cons. financial results for Q4 FY26 and the full financial year. This meeting will finalize the company's financial performance for the period.
Mar 28 2026 17:03:00
Read More

About Medplus Health Services

NSE : 7254  
BSE : 543427  
ISIN : INE804L01022  

Company was incorporated as ‘MedPlus Health Services Private Limited’ at Hyderabad Andhra Pradesh as a private limited company under the Companies Act 1956 and was granted the certificate of incorporation on November 30 2006 by the Registrar of Companies Andhra Pradesh at Hyderabad. Our Company was converted from a private limited company to a public limited company pursuant to a special resolution passed by our Shareholders at the EGM held on June 1 2021 and the name of our Company was changed to ‘MedPlus Health Services Limited’. Consequently a fresh certificate of incorporation was issued by the Registrar of Companies Telangana at Hyderabad on June 28 2021.Major events2007Pharmaceutica Ventures Limited invested ?800 million by subscribing to 45720 equity shares Peepul Capital Fund II LLC invested ? 226.33 million by subscribing to 30000 equity shares of the Company and NEA-IndoUS Venture Capital LLC invested $5 million by subscribing to 11620 equity shares of our Company (out of which 4662 equity shares through conversion of Series A CCPS.)2012EBITDA of our Company turned positive2017Gangadi Investments Private Limited acquired 122347 equity shares 12000000 unlisted redeemable preference shares and 42847000 non-convertible debentures from MKCP Direct Investments (Mauritius) IV Limited MKCP Institutional Investor (Mauritius) III Limited TVS Shriram Growth Fund IA and Indiaventure Trust – Fund I2019PI Opportunities Fund - I invested acquiring 22.21% stake of our Company as on date pursuant to purchase of 21233 equity shares2021Lavender Rose invested ?6.56 billion acquiring a 24.58% stake of our Company as on date through primary and secondary transactions.PI Opportunities Fund - I invested ?222.10 million by subscribing to 160147 Series C2 CCPS

Read More

Medplus Health Services Management

NamePosition
Manoj Kumar SrivastavaCompany Secretary & Compliance Officer
Gangadi Madhukar ReddyChairman, Managing Director & CEO
View More

Medplus Health Services FAQs

The Buying Price of Medplus Health Services share is 869.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Medplus Health Services stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Medplus Health Services, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Medplus Health Services shares is 50.89. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Medplus Health Services shares is 5.54. Useful to assess the stock's value relative to its book value.

To assess Medplus Health Services’s valuation compare Sector P/E, P/B which are 70.17 & 3.8 with sector averages, along with growth rates and financial metrics.

The Market Cap of Medplus Health Services is 10442.35 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Medplus Health Services share price is 1045.30 & 732.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Medplus Health Services belongs to the Retail Industry sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost